Information – Report Regarding Ocrelizumab

Please find attached the second report from MSNZ regarding Ocrelizumab and our Advocacy around this new disease modifying treatment.

All the information is also available the website here

Ocrelizumab is not yet registered with Medsafe or funded by PHARMAC in NZ but applications are underway.

Actively Advocating – Ocelizumab – July 2017